KBC Group
OLMA icon

KBC Group’s Olema Pharmaceuticals OLMA Stock Holding History

KBC Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17K Buy
+1,164
New +$25.9K ﹤0.01% 1846
2025
Q1 		– Sell
-4,075
Closed -$24K – 1891
2024
Q4 		$24K Buy
+4,075
New +$40.7K ﹤0.01% 1829

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

KBC Group's OLMA Position: Q1 2026 in Review

KBC Group opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 1,164 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #1846 among its holdings. This is a return to the name: KBC Group previously reported a position in OLMA as recently as Q4 2024.

KBC Group first reported a position in OLMA in Q4 2024 and has held it in 2 quarters since. The position peaked at $24K in Q4 2024. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • KBC Group held 1,164 shares of Olema Pharmaceuticals worth $17K as of Q1 2026.
  • Olema Pharmaceuticals was a new KBC Group position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1846 holding.
  • KBC Group first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 2 quarters since.
  • KBC Group's Olema Pharmaceuticals position peaked at $24K in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.